Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 08 Jul 2022 for Amylyx Pharmaceuticals, Inc., €351k. Read the official filing
Filing timeline
BuySaleALS Invest 1 B.V.
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
ALS Invest 1 B.V.: trading record in brief
ALS Invest 1 B.V. is a declared insider of Amylyx Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 11 January 2022 to 6 July 2022, the count stands at 2 filings.
Every open-market trade on record is a sale: 1 sale worth €351k.
Most recently, on 8 July 2022, the filings show an open-market sale worth €351k in Amylyx Pharmaceuticals, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to ALS Invest 1 B.V.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
18,312 shares@ US$19.54100.0% of flowCommon StockSEC:0000899243-22-025847:0
1,129,386 sharesCommon StockSEC:0000899243-22-016853:0
2 of 2 declarations
